Please use this identifier to cite or link to this item: http://hdl.handle.net/10739/2661
Title: Interference proceedings and innovation goals of the CRISPR-Cas9 patent
Authors: Tripathy, Sunita
Keywords: United States Patent and Trademark Office
USPTO
America Invents Act
US patent law
Patent Trial and Appeal Board
Issue Date: 1-Jan-2019
Publisher: Journal of Intellectual Property Law & Practice
Citation: Tripathy, S. (2019). Interference proceedings and innovation goals of the CRISPR-Cas9 patent. Journal of Intellectual Property Law & Practice, 14(1), 25–32. doi: 10.1093/jiplp/jpy106
Abstract: This article critically analyses one of the last interference proceedings before the United States Patent and Trademark Office (USPTO) since the America Invents Act (AIA) was passed. It examines the interference proceeding between University of California, Berkeley and the Broad Institute for the patent on the use of the Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing system, which was terminated by the Patent Trial and Appeal Board (PTAB) in February 2017. The aim is to review the ‘obviousness standard’ in US patent law and question whether, once the basics of a technique are well known, the application of the technology in different contexts becomes obvious too? How should inventorship be decided in such cases?
URI: http://hdl.handle.net/10739/2661
ISSN: 1747-1540
Appears in Collections:JGU Research Publications

Files in This Item:
File Description SizeFormat 
Interference proceedings and innovation goals.pdfInterference proceedings and innovation goals of the CRISPR-Cas9 patent165.97 kBAdobe PDFView/Open    Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.